Engineering Circadian Biology into Induced Pluripotent Stem Cell Organ-on-a-Chip Models
Engineering Circadian Biology into Induced Pluripotent Stem Cell Organ-on-a-Chip Models
批准号:
NC/X002152/1
负责人:
David Alan Lee
金额:
$25.72万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Organ-on-a chip (OOAC) devices are an emerging tool for studying how organs function and for testing new and repurposed drugs in a laboratory environment. Each chip contains hollow channels containing combinations of human cells that interact with each other to mimic the functioning of our organs. Mechanical forces can be applied to replicate the physical forces that cells experience in our tissues and organs, for example fluid flow and stretch for the heart and blood vessels. Ultimately OOAC systems may be used to reduce the use of animals in research and ultimately to replace routine use of animals altogether.All tissues in the body have an internal biological circadian 'clock' which co-ordinates cellular processes in our tissues and organs according to the time of day or night, creating cycles of biological function every 24h. Importantly drug effectiveness and toxicity often varies according to the time of administration, which means that there may be times of day when a drug is most effective and produces the least side effects. However, for the majority of treatments, the influence of biological time on therapeutic effectiveness has not been studied or exploited. This is partly because the early stages of a drug development, involving simple cell systems and then animal models do not replicate the human circadian clock. Accordingly, the first time a novel drug encounters a relevant human circadian clock is during phase I clinical trials many years into the development process. This results in costly late-stage failure of drug discovery programmes and the unnecessary use of animals in earlier stages of development. Currently circadian rhythms are not incorporated into OOAC technology and there is no means of establishing the biological time of cells within these devices, limiting the therapeutic and commercial potential of the technology. The overall aim of this project is, therefore, to incorporate the circadian clock into OOAC systems, allowing the cellular 'time of day' to be monitored and for drugs to be tested at different time points that reflect day and night for our organs.In this project we will develop cell lines from Induced Pluripotent Stem Cells (iPSCs) that are able to 'report' the time of the circadian clock. This involves using the gene editing technique CRISPR to link a luminescent tag to key genes that control the clock. Cellular circadian rhythms can then be induced and monitored non-invasively. iPSCs can be differentiated into all cell types in the body allowing us to develop a library of novel human iPSC-derived differentiated clock reporter cells. In this project we will turn the iPSCs into endothelial cells which line our blood vessels and skeletal muscle cells. The cells will be grown in OOAC devices and stimuli will be provided that 'set the time' of the clock resulting in the expression of clock genes, measured by luminescence, that will oscillate over a 24hr period. We will use a variety of stimuli to 'set the time' of the clock including chemical factors, such as growth factors and glucocorticoids, but also mechanical stimuli, such as fluid flow and stretch which are integral to OOAC devices. Finally we will look at whether known drugs have a different effect on the cells depending on when it is administered during the 24hr circadian rhythm. The ability to incorporate biological time into OOAC systems will make the systems better able to replicate the functioning of organs in our bodies and enhance their ability to be used as laboratory systems to replace the routine use of animals in research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BBSRC IAA Queen Mary University of London
-
批准号:BB/X511067/1
-
项目类别:Research Grant
-
资助金额:$50.33万
-
财政年份:2022
-
负责人:David Alan Lee
-
依托单位:
Mechno-regulation of genome function to direct stem cell fate
-
批准号:BB/N018532/1
-
项目类别:Research Grant
-
资助金额:$55.58万
-
财政年份:2017
-
负责人:David Alan Lee
-
依托单位:
Platform Grant: Multiscale Mechanobiology for Tissue Engineering
-
批准号:EP/E046975/1
-
项目类别:Research Grant
-
资助金额:$126.8万
-
财政年份:2007
-
负责人:David Alan Lee
-
依托单位:
Queen Mary, University of London - Discipline Bridging Initiative
-
批准号:G0502256/1
-
项目类别:Research Grant
-
资助金额:$45.33万
-
财政年份:2006
-
负责人:David Alan Lee
-
依托单位:
海外基金